Ryan W. Stidham, M.D.

Ryan Stidham, M.D., is a translational scientist caring exclusively for patients with Crohn's disease and ulcerative colitis. Dr. Stidham has advanced training in medical imaging physics, signals analysis, electronic data management, and Clinical Research Design and Statistical Analysis.

His research focus is technology development for improving measurement of IBD and other gastrointestinal diseases for both patient care and clinical trial endpoint development. Dr. Stidham's collaborative research team of mathematicians, engineers, and implementation scientists design and develop analytic pipelines to provide new interpretations of cross-sectional imaging, endoscopy, medical text, and other electronic data. Outside of developing digital approaches for improved endpoints, his work aims to automate high-labor-low-value aspects of clinical care and patient experience in real-world practice.  In additional to data analytics methods development and application, Dr. Stidham has expertise in clinical trial design endpoint testing.

Dr. Stidham's research has been supported by the National Institutes of Health, the Department of Defense, the National Science Foundation, the Crohn's and Colitis Foundation, the Broad Foundation, the Leona Helmsley Charitable Trust, and several industry-sponsored research collaborations. He has several awarded US patents, active external licenses for medical image analysis software, and is a co-founder of GI-focused image analysis startup company. He is the associate editor of artificial intelligence for the American Journal of Gastroenterology and is on the editorial board for Gastroenterology. He has published over 120 peer reviewed scientific manuscripts, book chapters, and review articles. He is also the recipient of the 2023 Rosenthal Lifetime Achievement Award from the Crohn's and Colitis Foundation in recognition of contributions to IBD.